Wells Fargo & Company Issues Pessimistic Forecast for Metagenomi (NASDAQ:MGX) Stock Price
Metagenomi (NASDAQ:MGX – Get Free Report) had its price objective lowered by stock analysts at Wells Fargo & Company from $25.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Other research analysts have also issued reports about the company. Chardan Capital reaffirmed […]
Metagenomi (NASDAQ:MGX – Get Free Report) had its price objective lowered by stock analysts at Wells Fargo & Company from $25.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Other research analysts have also issued reports about the company. Chardan Capital reaffirmed […]
